Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.
about
Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyCurrent and future directions for treating hepatitis B virus infectionOptimization therapy for the treatment of chronic hepatitis BPeg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatmentPersistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Risk stratification of HBV infection in Asia-Pacific region.HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patientsHepatitis B virus genotypes and variants.Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.Elimination of Hepatitis B: Is It a Mission Possible?A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.Different Mechanisms May Exist for HBsAg Synthesis and Secretion During Various Phases of Chronic Hepatitis B Virus Infection.Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patientsHBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?New therapeutic perspectives in HBV: when to stop NAs.Hepatitis B surface antigen quantification in chronic hepatitis B and its clinical utility.Treating Immune-tolerant Hepatitis B.What can we learn from hepatitis B virus clinical cohorts?New paradigms in hepatitis B management: only diamonds are forever.Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.Hepatitis B surface antigen in late hepatitis B infection.HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers.Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.Unmet Needs in Clinical and Basic Hepatitis B Virus Research.Immunopathogenesis of Hepatitis B Virus.Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNAHBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
P2860
Q26740161-A57590BD-49C5-44DF-A975-70D3A5E340C8Q26851240-DE72D1B1-88C9-452E-A2AC-3B34AE911CD0Q33626813-FC1DFD05-FDD4-4F87-B275-D2260DB3F9ADQ33734554-3B97853B-6E13-4A59-BDF6-8AF1D2EFFE7EQ33745110-78D2BA75-858C-4CC7-B1E9-61076AAB1553Q34289969-E55E4121-4554-4AE6-9242-3C0D3FF859BAQ34339577-EA7664CB-6159-4A3B-8058-9D33EAAC3775Q34505113-299FDEF0-586F-40B5-82EA-EA115DC704B8Q35663838-BCCA0F5C-29EF-441C-95BA-D9975E25572CQ36093940-D03A9100-8C38-43CA-AF45-0A6A6781BB32Q36307834-34CD7F5E-9381-47F7-935C-43BD2576B5C3Q36653514-D9FBB975-E2C1-4CD4-95CB-EA681C32A3E4Q37726148-F67611AB-1780-48CD-B08B-69F58C1C8469Q37727852-ED35A1CB-3441-4FE3-AEED-DE95FB0CF980Q37737334-07E329AC-282D-4428-8966-1D204EA356FDQ38174259-058BFC9A-4599-4723-950A-1906AC2C769CQ38174265-93ABBDEF-DE43-4840-9B87-BF180BB5EC99Q38177851-20C7990D-D752-4509-BB42-25A5477DF380Q38271430-CBB25525-BA75-4B10-BE86-CA4FC8665CB0Q38295846-92A77595-7453-4852-8BE5-A23154A07D03Q38588187-7815FE1F-E52F-473C-940E-B7C49463276BQ39864436-33F8DC69-62B3-45A5-BEFB-99643C6A1991Q40121899-988C398D-348F-487E-9E4C-433E76E52437Q40736922-B03E5B32-530D-4ECD-B7B5-5879E4E839A9Q40817492-B4FC731F-368D-49C5-8E39-D3A70930905DQ41284684-995C79F1-317D-472E-A143-FA1FBFF8FB1DQ41328399-F9CDEE05-253A-4215-B3E2-34419BD69799Q41441778-A9451253-471D-4092-B40B-AA8C970373BEQ41532357-ABFF770B-577A-4174-8421-6236BA814750Q42244591-C7F357FC-3241-474A-B96A-A0DFABBECE8EQ42245695-62FF6C26-BE06-40D1-8DBB-1E5F74B7F259Q42683825-9F0A27D2-F8B4-44E6-9302-3960DB93BDA8Q45324577-7FBF74FD-8518-4E9B-B9E2-DCC2555E12CEQ45324580-009CD13C-5455-4C94-A942-117B69A654D8Q47942045-8DD435D2-311F-4998-8804-0B858E891C75Q50190669-6F762169-2494-4F46-9A59-5050F3666C62Q55035830-931B68BE-16DB-4DD8-972F-0C411D9A15F5Q57491223-33AA3C6F-D53C-4B93-B838-F80B5216732AQ58548875-E9EE0C53-90E4-49DC-8939-A2100552BCA2
P2860
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical utility of quantitati ...... titis B: new trick of old dog.
@en
type
label
Clinical utility of quantitati ...... titis B: new trick of old dog.
@en
prefLabel
Clinical utility of quantitati ...... titis B: new trick of old dog.
@en
P2860
P921
P1476
Clinical utility of quantitati ...... titis B: new trick of old dog.
@en
P2093
Jia-Horng Kao
Tai-Chung Tseng
P2860
P356
10.1007/S00535-012-0668-Y
P577
2012-10-24T00:00:00Z
2013-01-01T00:00:00Z